Inovox Menthol

Lidocaine Hydrochloride, the active ingredient in Inovox Menthol, is a local anesthetic presented as an oral mucosal formulation for oromucosal use. It provides relief of sore throat and oral mucosal pain in adults and children. GNH USA supplies Inovox Menthol as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Inovox Menthol acts on the oral mucosa to alleviate discomfort associated with inflammatory conditions of the throat and mouth. - Sore throat: provides topical analgesia and reduces pain during swallowing. - Oral mucosal pain: alleviates discomfort from lesions, ulcers or irritation. - Pharyngitis: helps relieve throat pain and irritation caused by infection or inflammation.

Inovox Menthol may cause local and systemic reactions following oromucosal application. Common Side Effects: - Mild burning or tingling sensation at the site of application. - Transient numbness of the oral mucosa. - Temporary alteration of taste perception. - Mild dryness of the mouth. - Slight irritation or redness of the mucosal surface. Serious or Rare Side Effects: - Allergic reactions such as rash, urticaria or angioedema. - Severe oral irritation or ulceration. - Anaphylactic shock (rare). - Systemic toxicity from excessive lidocaine absorption (e.g., dizziness, seizures).

Before using Inovox Menthol, consider the following safety measures. - Allergy assessment: avoid if known hypersensitivity to lidocaine, amylmetacresol or 2,4‑dichlorobenzyl alcohol. - Age considerations: use with caution in young children; follow prescriber guidance. - Pregnancy: consult a healthcare professional before use during pregnancy or lactation. - Concomitant oral medications: evaluate for additive local‑anaesthetic effects. - Storage: Store below 25°C: keep in the original pack, protect from moisture and light.

Inovox Menthol can interact with other agents that affect local anaesthetic activity or mucosal integrity. Major Interactions (Avoid): - Other lidocaine‑containing products: risk of cumulative systemic toxicity. - Systemic lidocaine formulations: avoid concurrent use to prevent overdose. - Monoamine oxidase inhibitors (MAOIs): may increase systemic absorption risk. Moderate Interactions (Monitor Closely): - Alcohol‑containing mouthwashes: may enhance mucosal irritation. - Antihistamines: may mask early signs of an allergic reaction. - Topical corticosteroids: may alter mucosal healing; monitor for delayed recovery.